Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study).
J Dermatolog Treat
; 34(1): 2246606, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37587870
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Quality of Life
Type of study:
Etiology_studies
/
Observational_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
J Dermatolog Treat
Journal subject:
DERMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Italy